Advances in COVID-19 and Cancer Research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in COVID-19 and Cancer Research

Published:2024-07-16 Issue:14 Volume:13 Page:4143
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Franza Laura¹²^ORCID,Cianci Rossella¹³^ORCID

Affiliation:

1. Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy

2. Emergency Department, Azienda Ospedaliero-Universitaria di Modena, Largo del Pozzo, 71, 41125 Modena, Italy

3. Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy

Abstract

The global health crisis caused by COVID-19 has radically changed the management of several diseases [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/2077-0383/13/14/4143/pdf

Reference9 articles.

1. Debie, Y., Palte, Z., Salman, H., Verbruggen, L., Vanhoutte, G., Chhajlani, S., Raats, S., Roelant, E., Vandamme, T., and Peeters, M. (2024). Long-term effects of the COVID-19 pandemic for patients with cancer. Qual. Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil.

2. Li, J., Zhang, Y., Yang, Y.G., and Sun, T. (2024). Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems. Mol. Pharm.

3. Dong, L., Deng, X., Li, Y., Zhu, X., Shu, M., Chen, J., Luo, H., An, K., Cheng, M., and Zhang, P. (2024). Stimuli-Responsive mRNA Vaccines to Induce Robust CD8(+) T Cell Response via ROS-Mediated Innate Immunity Boosting. J. Am. Chem. Soc.

4. The Importance of Complying with Vaccination Protocols in Developed Countries: “Anti-Vax” Hysteria and the Spread of Severe Preventable Diseases;Pandolfi;Curr. Med. Chem.,2018

5. Gabrielli, M., Franza, L., Esperide, A., Gasparrini, I., Gasbarrini, A., Franceschi, F., and on behalf of GEMELLI AGAINST COVID 2019 (2022). Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines, 10.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3